POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Clinical trials for POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for transplant patients with rare lymphoma
Disease control Recruiting nowThis study tests a combination of two drugs (polatuzumab vedotin and rituximab) as a first treatment for a type of lymphoma that can occur after an organ or stem cell transplant. The goal is to see if this combo is safe and works better than current options, potentially avoiding …
Matched conditions: POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New cell therapy aims to knock out EBV after transplant
Disease control Recruiting nowThis study is testing a new treatment called EBV-AST cells for people who have an EBV infection after a stem cell transplant. The goal is to find the safest dose and see if it can clear the virus from the blood. About 18 adults aged 18-75 who have had a stem cell transplant and h…
Matched conditions: POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE1, PHASE2 • Sponsor: Daihong Liu • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC